In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy

The mRNA-based Covid vaccines used by hundreds of millions of people may provide an unexpected benefit to some cancer patients, significantly improving survival when given …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Former Pear Therapeutics executives start new VC firm, with biotech veteran Bob Langer as adviser

Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech

August 23, 2023

New way to administer CAR-T-cell therapy could lead to fewer side effects

When Richard O’Neil, Ph.D., joined MUSC Hollings Cancer Center two years ago, he knew that he wanted to continue finding ways to make CAR-T-cell therapy

September 8, 2023

Risk Adjusted Net Present Value: What is the current valuation of Atai Life Sciences’s RL-007

The revenue for RL-007 is expected to reach an annual total of $101 mn by 2038 in the US based off GlobalData’s Expiry Model. The

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.